Published September 5, 2017
| Version v1
Journal article
Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery
- Others:
- Centre méditerranéen de médecine moléculaire (C3M) ; Université Nice Sophia Antipolis (1965 - 2019) (UNS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UniCA)
- Centre Hospitalier Universitaire de Nice (CHU Nice)
- Hôpital Archet 2 [Nice] (CHU)
- Université Côte d'Azur, Inserm, Centre Méditerranéen de Médecine Moléculaire (C3M), Team "Chronic Liver Diseases Associated with Steatosis"
- Pôle Digestif ; Centre Hospitalier Universitaire de Nice (CHU Nice)-Hôpital l'Archet
- ANR-11-LABX-0028,SIGNALIFE,Réseau d'Innovation sur les Voies de Signalisation en Sciences de la Vie(2011)
- ANR-15-CE14-0016,HEPAMETOL,INTERACTION ENTRE ALCOOL ET L'OBÉSITÉ DANS LA SÉVÉRITÉ DES MALADIES DU FOIE GRAS.(2015)
Description
Overweight and obesity dramatically increased in the last years. Hepatic complication of obesity, integrated in the term of non-alcoholic fatty liver disease (NAFLD), is a spectrum of abnormality ranging from steatosis to non-alcoholic steatohepatitis (NASH), potentially leading to cirrhosis. Liver biopsy remains the gold standard to evaluate the stage of NAFLD; however, the procedure is invasive. The indocyanine green (ICG) clearance test is performed since years to assess hepatic function before partial hepatectomy, or after liver transplantation. This study was designed to detect liver complications with the ICG clearance test in a population of obese patients scheduled for bariatric surgery.
Abstract
International audience
Additional details
- URL
- https://hal.science/hal-04496706
- URN
- urn:oai:HAL:hal-04496706v1
- Origin repository
- UNICA